Fractional Flow Reserve Market

Fractional Flow Reserve Market by Technology (Invasive Monitoring, Non-invasive Monitoring), Invasive Monitoring Product (Pressure Guidewires, FFR Measurement Systems), Application, and Region - Global Forecast to 2024

Report Code: MD 7059 Apr, 2019, by marketsandmarkets.com

[105 Pages Report] The fractional flow reserve market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period. Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR.

Fractional Flow Reserve Market

By technology, the invasive monitoring segment is estimated to hold the largest share of the fractional flow reserve market

Based on technology, the fractional flow reserve market is segmented into invasive and non-invasive monitoring. The invasive monitoring segment accounted for the largest share of the market in 2018. The large share of this segment can be attributed to the strong recommendation for FFR usage in coronary angiography by the American College of Cardiology, American Heart Association, European Society of Cardiology (ESC), and the European Association for Cardio-Thoracic Surgery (EACTS).

Pressure Guidewires to dominate fractional flow reserve market during the forecast period

On the basis of type, the invasive monitoring market is segmented into pressure guidewires and FFR monitoring systems. The pressure guidewires segment accounted for the larger market share in 2018. This can be attributed to the growth in the number of PCI procedures (as a result of the rising prevalence of CVD), strong recommendation for guided revascularization by measuring FFR in specific clinical scenarios, and the single-use nature of pressure guidewires.

Multi-vessel diseases segment to grow at the fastest rate during the forecast period

On the basis of application, the fractional flow reserve market is segmented into single-vessel diseases and multi-vessel diseases. In 2018, the single-vessel diseases segment accounted for the larger share of the fractional flow reserve market. The large share of this segment can be attributed to the high prevalence of single-vessel coronary artery disease.

Fractional Flow Reserve Market

North America is expected to hold the largest market share during the forecast period

North America is the major revenue-generating region in the fractional flow reserve market. The fractional flow reserve market in the region is driven by high healthcare spending in the region, rising prevalence of CVD and lifestyle diseases, growth in the geriatric population, a large number of ongoing research activities and product launches, availability of reimbursements, and the rapid adoption of technologically advanced imaging systems.

Key Market Players

The key players in the fractional flow reserve market are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands).

Recent Developments

  • In 2017, Abbott acquired St. Jude Medical, Inc., one of the leading players in cardiovascular and neuromodulation products.
    Abbott Laboratories is a healthcare company that develops, manufactures, and markets a broad and diverse range of health care products. The company operates through four business segments, namely, Established Pharmaceuticals, Diagnostic Products, Nutritional Products, and Cardiovascular and Neuromodulation Products. The company is present in Africa, Asia Pacific, Europe, Latin America, the Middle East, North America, and South America.
  • In 2017, HeartFlow, Inc. entered into an agreement with Royal Philips
    Founded in 2007 and headquartered in California (US), HeartFlow is a personalized medical technology company seeking to transform the way cardiovascular disease is diagnosed and treated. The company provides Heartflow FFR-CT, the first available non-invasive solution that enables a physician to more accurately evaluate whether a patient has significant coronary artery disease (CAD) based on both anatomy and physiology. HeartFlow FFRct leverages deep learning to create a personalized 3D model of the patient’s arteries. Through this agreement, Philips will promote the use of the HeartFlow FFRct Analysis in conjunction with Philips’ advanced catheters for the imaging and assessment of a patient’s coronary arteries.
  • In 2015, Philips acquired Volcano Corporation
    Philips operates as a health technology company worldwide. The company offers products for diagnostic imaging, image-guided therapy, patient monitoring, health informatics, consumer health, and home care. The company offers its products through four segments—Diagnosis & Treatment, Connected Care & Health Informatics, Personal Health, and Other. Philips operates across 100 countries across the globe, including key and high growth markets such as the US, France, South Africa, and Singapore. The acquisition provided Philips access to Volcano’s image-guided minimally invasive surgery solutions.

Key Questions addressed by the report

  • Which are the key players in the market, and how intense is the competition?
  • Emerging countries present immense opportunities for the growth of fractional flow reserve market. Will this situation persist?
  • Which product markets will dominate in the future?
  • What are the challenges hindering the adoption of fractional flow reserve solutions?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Market Data Validation and Triangulation
    2.3 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 28)
    4.1 Fractional Flow Reserve: Market Overview
    4.2 North America: Fractional Flow Reserve Market, By Technology (2018)
    4.3 Fractional Flow Reserve Market: Geographic Growth Opportunities

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Geriatric Population and the Subsequent Growth in the Prevalence of CVD
                    5.2.1.2 Cost Benefit and Favorable Reimbursement Scenario
           5.2.2 Restraints
                    5.2.2.1 Reluctance of Interventional Cardiologists to Adopt FFR
           5.2.3 Opportunities
                    5.2.3.1 Growth Potential in Emerging Economies
           5.2.4 Challenges
                    5.2.4.1 Technical Limitations of Invasive FFR

6 Fractional Flow Reserve Market, By Technology (Page No. - 35)
    6.1 Introduction
    6.2 Invasive Monitoring
           6.2.1 Pressure Guidewires
                    6.2.1.1 Growth in the Number of Pci Procedures to Drive the Demand for Pressure Guidewires
           6.2.2 FFR Measurement Systems
                    6.2.2.1 Monitoring Systems are Multi-Modal and Offer the Options to Change the Modality Based on the Examination Required
    6.3 Non-Invasive Monitoring
           6.3.1 No Risk of Procedural Complications and Presence of Clinical Evidence Supporting Its Efficacy are the Major Factors Driving the Demand for Non-Invasive Monitoring

7 Fractional Flow Reserve Market, By Application (Page No. - 41)
    7.1 Introduction
    7.2 Single-Vessel Diseases
           7.2.1 Single-Vessel Diseases Dominate the Market, By Application
    7.3 Multi-Vessel Diseases
           7.3.1 Superior Outcomes, Product Launches are Driving Growth in the Multi-Vessel Diseases Segment

8 Fractional Flow Reserve Market, By Region (Page No. - 45)
    8.1 Introduction
    8.2 North America
           8.2.1 US
                    8.2.1.1 US Commands the Largest Share of the North American Market
           8.2.2 Canada
                    8.2.2.1 Rising Incidence and Prevalence of CVD Will Support Market Growth in Canada
    8.3 Europe
           8.3.1 Germany
                    8.3.1.1 Germany Dominates the European Market for Fractional Flow Reserve Devices
           8.3.2 France
                    8.3.2.1 Rapid Growth in the Aging Population and Availability of Reimbursement are Key Growth Drivers for the French Market
           8.3.3 UK
                    8.3.3.1 The Rising Number of Percutaneous Coronary Interventions Will Boost Market Growth in the UK
           8.3.4 Italy
                    8.3.4.1 Escalating Costs are Driving Attention Toward Value-Based Healthcare in Italy
           8.3.5 Spain
                    8.3.5.1 Rising Lifestyle Disease Prevalence has Contributed to the Overall Number of CVD Cases in Spain
           8.3.6 Rest of Europe
    8.4 Asia Pacific
           8.4.1 China
                    8.4.1.1 China’s Large Population Makes It A Key Market for Fractional Flow Reserve Devices
           8.4.2 Japan
                    8.4.2.1 Availability of Health Insurance has Enabled Easy Access to Healthcare
           8.4.3 India
                    8.4.3.1 Growth in the Aging Population and Rising Prevalence of CVD are Driving the Demand for Imaging Technologies in India
           8.4.4 Rest of Asia Pacific
    8.5 Rest of the World

9 Competitive Landscape (Page No. - 77)
    9.1 Introduction
    9.2 Market Share Analysis
           9.2.1 Abbott Laboratories
           9.2.2 Koninklijke Philips N.V.
           9.2.3 Boston Scientific Corporation
    9.3 Competitive Scenario/Competitive Situation and Trends
           9.3.1 Product Launches
           9.3.2 Agreements, Collaborations, and Partnerships
           9.3.3 Acquisitions

10 Company Profile (Page No. - 81)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     10.1 Abbott
     10.2 Koninklijke Philips N.V.
     10.3 Boston Scientific Corporation
     10.4 Acist Medical Systems (Subsidiary of Bracco Diagnostic Inc)
     10.5 Opsens
     10.6 Heartflow, Inc.
     10.7 Siemens Healthineers
     10.8 Pie Medical Imaging
     10.9 Cathworks
     10.10 Medis Medical Imaging Systems Bv

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

11 Appendix (Page No. - 99)
     11.1 Discussion Guide
     11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     11.3 Available Customizations
     11.4 Related Reports
     11.5 Author Details


List of Tables (64 Tables)

Table 1 Fractional Flow Reserve: Market, By Technology, 2017–2024 (USD Million)
Table 2 Invasive Monitoring Market, By Region, 2017–2024 (USD Million)
Table 3 Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 4 Pressure Guidewires Market, By Region, 2017–2024 (USD Million)
Table 5 FFR Measurement Systems Market, By Region, 2017–2024 (USD Million)
Table 6 Non-Invasive Monitoring Market, By Region, 2017–2024 (USD Million)
Table 7 Market, By Application, 2017–2024 (USD Million)
Table 8 Market for Single-Vessel Diseases, By Region, 2017–2024 (USD Million)
Table 9 Market for Multi-Vessel Diseases, By Region, 2017–2024 (USD Million)
Table 10 Market, By Region, 2017–2024 (USD Million)
Table 11 North America: Market, By Country, 2017–2024 (USD Million)
Table 12 North America: Market, By Technology, 2017–2024 (USD Million)
Table 13 North America: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 14 North America: Market, By Application, 2017–2024 (USD Million)
Table 15 US: Market, By Technology, 2017–2024 (USD Million)
Table 16 US: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 17 US: Market, By Application, 2017–2024 (USD Million)
Table 18 Canada: Market, By Technology, 2017–2024 (USD Million)
Table 19 Canada: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 20 Canada: Market, By Application, 2017–2024 (USD Million)
Table 21 Europe: Market, By Country, 2017–2024 (USD Million)
Table 22 Europe: Market, By Technology, 2017–2024 (USD Million)
Table 23 Europe: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 24 Europe: Market, By Application, 2017–2024 (USD Million)
Table 25 Germany: Market, By Technology, 2017–2024 (USD Million)
Table 26 Germany: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 27 Germany: Market, By Application, 2017–2024 (USD Million)
Table 28 France: Market, By Technology, 2017–2024 (USD Million)
Table 29 France: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 30 France: Market, By Application, 2017–2024 (USD Million)
Table 31 UK: Market, By Technology, 2017–2024 (USD Million)
Table 32 UK: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 33 UK: Market, By Application, 2017–2024 (USD Million)
Table 34 Italy: Market, By Technology, 2017–2024 (USD Million)
Table 35 Italy: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 36 Italy: Market, By Application, 2017–2024 (USD Million)
Table 37 Spain: Market, By Technology, 2017–2024 (USD Million)
Table 38 Spain: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 39 Spain: Market, By Application, 2017–2024 (USD Million)
Table 40 RoE: Market, By Technology, 2017–2024 (USD Million)
Table 41 RoE: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 42 RoE: Market, By Application, 2017–2024 (USD Million)
Table 43 Asia Pacific: Market, By Country, 2017–2024 (USD Million)
Table 44 Asia Pacific: Market, By Technology, 2017–2024 (USD Million)
Table 45 Asia Pacific: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 46 Asia Pacific: Market, By Application, 2017–2024 (USD Million)
Table 47 China: Market, By Technology, 2017–2024 (USD Million)
Table 48 China: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 49 China: Market, By Application, 2017–2024 (USD Million)
Table 50 Japan: Market, By Technology, 2017–2024 (USD Million)
Table 51 Japan: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 52 Japan: Market, By Application, 2017–2024 (USD Million)
Table 53 India: Market, By Technology, 2017–2024 (USD Million)
Table 54 India: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 55 India: Market, By Application, 2017–2024 (USD Million)
Table 56 RoAPAC: Market, By Technology, 2017–2024 (USD Million)
Table 57 RoAPAC: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 58 RoAPAC: Market, By Application, 2017–2024 (USD Million)
Table 59 RoW: Market, By Technology, 2017–2024 (USD Million)
Table 60 RoW: Invasive Monitoring Market, By Product, 2017–2024 (USD Million)
Table 61 RoW: Market, By Application, 2017–2024 (USD Million)
Table 62 Product Launches
Table 63 Agreements, Collaborations, and Partnerships
Table 64 Acquisitions


List of Figures (29 Figures)

Figure 1 Market Segmentation
Figure 2 Market: Research Methodology
Figure 3 Research Design
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Market, By Technology, 2019 vs 2024 (USD Million)
Figure 9 Invasive Monitoring Market, By Product, 2019 vs 2024 (USD Million)
Figure 10 Market, By Application, 2019 vs 2024 (USD Million)
Figure 11 North America Accounted for the Largest Share of the Fractional Flow Reserve: Market in 2018
Figure 12 Increasing Prevalence of Cardiovascular Diseases is the Key Factor Driving the Growth of This Market
Figure 13 Invasive Monitoring Segment Accounted for the Largest Share of the North American Fractional Flow Reserve Market in 2018
Figure 14 Asia Pacific Market to Register the Highest Growth Rate During the Forecast Period
Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Market, By Technology, 2019 vs 2024 (USD Million)
Figure 17 Market, By Application, 2019 vs 2024 (USD Million)
Figure 18 Market, By Region, 2019 & 2024
Figure 19 North America: Fractional Flow Reserve: Market Snapshot
Figure 20 Europe: Fractional Flow Reserve: Market Snapshot
Figure 21 Asia Pacific: Fractional Flow Reserve: Market Snapshot
Figure 22 RoW: Fractional Flow Reserve: Market Snapshot
Figure 23 Market Share Ranking, By Key Player (2018)
Figure 24 Strategies Adopted By Market Players (2015–2018)
Figure 25 Company Snapshot: Abbott (2018)
Figure 26 Koninklijke Philips N.V.: Company Snapshot (2018)
Figure 27 Boston Scientific: Company Snapshot (2018)
Figure 28 Company Snapshot: Opsens, Inc (2018)
Figure 29 Company Snapshot: Siemens Healthineers (2018)

The study involved four major activities in estimating the current market size for fractional flow reserve market. Exhaustive secondary research was done to collect information about the market, peer markets, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Thirdly, both top-down and bottom-up approaches were employed to estimate the complete market size. Finally, the market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as the American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), Cardiovascular Health Study (CHS), American College of Cardiology (ACC), American College of Cardiology Foundation (ACCF), Canadian Chronic Disease Surveillance System (CCDSS), Canadian Association of Interventional Cardiology, German Cardiac Society, European Association of Percutaneous Cardiovascular Interventions (EAPCI), French Cardiac Society, French Group of Atheroma and Interventional Cardiology (GACI), Organisation for Economic Co-operation and Development (OECD), The British Cardiovascular Society, British Society of Cardiovascular Imaging (BSCI), National Health Service (NHS), National Congress Italian Society of Invasive Cardiology (GISE), Italian Society of Cardiology, Spanish Society of Cardiology, Spanish Cardiac Catheterization and Coronary Intervention Registry, Turkish Society of Cardiology, Belorussian Society of Cardiologists, Annual Reports, Press Releases, and Corporate Presentations, have been used to identify and collect information useful for the study of this market.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the fractional flow reserve market. The primary sources from the demand side include personnel from interventional cardiologists, research organizations, academic institutes, and purchase managers.

  • A robust primary research methodology has been adopted to validate the contents of the report
  • Both telephonic and e-mail interviews of primary participants were conducted through questionnaires

A breakdown of primary respondents is provided below:

Fractional Flow Reserve Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down and bottom-up approaches were used to validate the size of the fractional flow reserve market and estimate the size of other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry’s market size, in terms of value, was determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the fractional flow reserve market by technology, application, and region
  • To provide detailed information regarding factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To strategically analyze the market structure and profile the key players of the fractional flow reserve market and comprehensively analyze their core competencies
  • To forecast the size of the market segments in North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To track and analyze competitive developments such as product launches and approvals, acquisitions, partnerships, collaborations, and agreements

Scope of the report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019-2024

Forecast units

Value (USD)

Segments covered

Technology, Application, and Region

Geographies covered

North America, Europe, Asia Pacific, and RoW

Companies covered

Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands)

This research report categorizes the fractional flow reserve market based on technology, application, and region.

On the basis of Technology, the fractional flow reserve market has been segmented as follows:

  • Invasive Monitoring
    • Pressure Guidewires
    • FFR Measurement Systems
  • Non-invasive Monitoring

On the basis of Application, the fractional flow reserve market has been segmented as follows:

  • Single-vessel Diseases
  • Multi-vessel Diseases

On the basis of region, the fractional flow reserve market has been segmented as follows:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)
Report Code
MD 7059
Published ON
Apr, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Fractional Flow Reserve Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home